AIM · ISSUER CIK 946644
AIM ImmunoTech Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 AIM ImmunoTech Inc. insiders reported $24K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Equels Thomas K (CEO & President, Director), with $24K.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$24KInsider buying
$0.00Insider selling
+$24KNet open-market
Oct 26, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 202612:12 | Oct 23, 2026 | AIM | CEO & President, Director | P · Buy | $0.16 | +31,675 | 189,747 | +20% | +$5K | -44.8% | 0.0% |
| Oct 23, 202612:29 | Oct 22, 2026 | AIM | CEO & President, Director | P · Buy | $0.16 | +31,250 | 158,072 | +25% | +$5K | -43.8% | -1.8% |
| Sep 18, 202608:30 | Sep 17, 2026 | AIM | CEO & President, Director | P · Buy | $0.21 | +24,000 | 126,822 | +23% | +$5K | -45.3% | -23.1% |
| Sep 17, 202612:01 | Sep 16, 2026 | AIM | CEO & President, Director | P · Buy | $0.21 | +11,000 | 102,822 | +12% | +$2K | -44.7% | -23.8% |
| Sep 16, 202609:15 | Sep 15, 2026 | AIM | CEO & President, Director | P · Buy | $0.22 | +22,000 | 91,822 | +32% | +$5K | -44.8% | -27.6% |
| Sep 15, 202616:30 | Sep 14, 2026 | AIM | CEO & President, Director | P · Buy | $0.22 | +5,900 | 69,822 | +9% | +$1K | -46.6% | -26.9% |